Cargando…

Correspondence to Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults

Detalles Bibliográficos
Autores principales: Chu, Wei-Min, Lee, Yung-Heng, Wei, James Cheng-Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384567/
https://www.ncbi.nlm.nih.gov/pubmed/35880589
http://dx.doi.org/10.1093/infdis/jiac309
_version_ 1784769450600300544
author Chu, Wei-Min
Lee, Yung-Heng
Wei, James Cheng-Chung
author_facet Chu, Wei-Min
Lee, Yung-Heng
Wei, James Cheng-Chung
author_sort Chu, Wei-Min
collection PubMed
description
format Online
Article
Text
id pubmed-9384567
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-93845672022-08-18 Correspondence to Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults Chu, Wei-Min Lee, Yung-Heng Wei, James Cheng-Chung J Infect Dis Letter to the Editor Oxford University Press 2022-07-26 /pmc/articles/PMC9384567/ /pubmed/35880589 http://dx.doi.org/10.1093/infdis/jiac309 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Letter to the Editor
Chu, Wei-Min
Lee, Yung-Heng
Wei, James Cheng-Chung
Correspondence to Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults
title Correspondence to Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults
title_full Correspondence to Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults
title_fullStr Correspondence to Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults
title_full_unstemmed Correspondence to Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults
title_short Correspondence to Recombinant Adjuvanted Zoster Vaccine and Reduced Risk of Coronavirus Disease 2019 Diagnosis and Hospitalization in Older Adults
title_sort correspondence to recombinant adjuvanted zoster vaccine and reduced risk of coronavirus disease 2019 diagnosis and hospitalization in older adults
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9384567/
https://www.ncbi.nlm.nih.gov/pubmed/35880589
http://dx.doi.org/10.1093/infdis/jiac309
work_keys_str_mv AT chuweimin correspondencetorecombinantadjuvantedzostervaccineandreducedriskofcoronavirusdisease2019diagnosisandhospitalizationinolderadults
AT leeyungheng correspondencetorecombinantadjuvantedzostervaccineandreducedriskofcoronavirusdisease2019diagnosisandhospitalizationinolderadults
AT weijameschengchung correspondencetorecombinantadjuvantedzostervaccineandreducedriskofcoronavirusdisease2019diagnosisandhospitalizationinolderadults